Finding the Path in Alzheimer’s Disease Early Diagnosis to Ongoing Collaborative Care【電子書籍】[ Sharon Cohen, MD, FRCPC ]

＜p＞AD is a common neurodegenerative condition that results in a range of profoundly disabling cognitive, affective, and behavioral symptoms. It affects approximately 5.8 million Americans. Barring significant clinical efforts and medical breakthroughs that prevent or slow disease development, current estimates suggest that by 2050, AD will afflict 14 million patients in the United States. PCPs are on the front lines of early diagnosis of AD, yet many say they feel unprepared and their community lacks adequate specialists in this area. Signs and symptoms of mild cognitive impairment (MCI) and even early AD are often conflated with normal aging, leading to late or missed diagnosis. This is compounded by the lack of a sense of urgency for early, accurate diagnosis because there are no disease-modifying therapies to treat MCI or AD. This ＜em＞eHealth Source＜/em＞ activity reviews the pathophysiology of AD, early signs and symptoms, diagnosis first steps, referral patterns, more-complex diagnostic procedures, and existing nonpharmacologic and pharmacologic management strategies. Drs Cohen and Turner provide expert insight into how PCPs can tailor their practice to better care for these patients.＜/p＞画面が切り替わりますので、しばらくお待ち下さい。

※ご購入は、楽天kobo商品ページからお願いします。

※切り替わらない場合は、こちら をクリックして下さい。

※このページからは注文できません。